{"name":"Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW","slug":"belgian-inflammatory-bowel-disease-research-and-development-bird-vzw","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"infliximab+azathioprine","genericName":"infliximab+azathioprine","slug":"infliximab-azathioprine","indication":"Moderate to severe Crohn's disease","status":"marketed"},{"name":"methylprednisolone or budesonide","genericName":"methylprednisolone or budesonide","slug":"methylprednisolone-or-budesonide","indication":"Inflammatory bowel disease (Crohn's disease and ulcerative colitis)","status":"marketed"}]}],"pipeline":[{"name":"infliximab+azathioprine","genericName":"infliximab+azathioprine","slug":"infliximab-azathioprine","phase":"marketed","mechanism":"Infliximab blocks TNF-α to reduce inflammation while azathioprine suppresses immune cell proliferation, providing dual immunosuppression for inflammatory bowel disease.","indications":["Moderate to severe Crohn's disease","Moderate to severe ulcerative colitis"],"catalyst":""},{"name":"methylprednisolone or budesonide","genericName":"methylprednisolone or budesonide","slug":"methylprednisolone-or-budesonide","phase":"marketed","mechanism":"Both methylprednisolone and budesonide are corticosteroids that suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Inflammatory bowel disease (Crohn's disease and ulcerative colitis)","Acute exacerbations of IBD"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}